{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:08:13Z","timestamp":1795090093023,"version":"4.10.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes and Environ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disease that results in the development of more than 100 polyps, premalignant lesions, in the colorectum. Therefore, patients with FAP are a high-risk group for colorectal cancer (CRC). The only standard method of preventing CRC is total colectomy. Thus, alternative methods to prevent the development of CRC are desired by patients. Epidemiological and animal studies suggested that green tea and its extracts, such as (\u2212)-epigallocatechin gallate, may have the potential to prevent cancer development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the present study, we evaluated the suppressive effects of green tea extract (GTE) on suppress colorectal polyps in FAP and conducted a double-blind clinical trial. Eighty patients were randomly assigned to the GTE group (1.5\u2009g\/day for 2\u2009years) and an equal number were assigned to the placebo group. The primary endpoint of colon polyp enlargement tended to be reduced in the GTE group compared with the placebo group, with a risk ratio of 0.43 (95% confidence interval 0.12\u20131.49;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.16).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Given that the risk ratio was less than 0.5 and few adverse events were observed, we believe that further research using GTE after calculating the necessary sample size is calculated on the based of this study, should be considered in a future large-scale clinical trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41021-026-00354-2","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:55:20Z","timestamp":1772445320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential of green tea extract to suppress colorectal polyp development in patients with familial adenomatous polyposis: a double-blind, randomized controlled trial Japan Familial Adenomatous Polyposis Prevention Study (J-FAPP Study I)"],"prefix":"10.1186","volume":"48","author":[{"given":"Hideki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomiyo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"J-FAPP Study I Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"4","key":"354_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10147-004-0414-4","volume":"9","author":"T Iwama","year":"2004","unstructured":"Iwama T, Tamura K, Morita T, et al. A clinical overview of familial adenomatous polyposis derived from the database of the polyposis registry of Japan. Int J Clin Oncol. 2004;9(4):308\u201316.","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"354_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/a-1945-9120","volume":"55","author":"H Ishikawa","year":"2023","unstructured":"Ishikawa H, Yamada M, Sato Y, et al. Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis (J-FAPP study III): a multicenter prospective interventional study. Endoscopy. 2023;55(4):344\u201352.","journal-title":"Endoscopy"},{"key":"354_CR3","first-page":"A657","volume":"118","author":"C Burke","year":"2000","unstructured":"Burke C, van Stolk R, Arber N, et al. Exisulind prevents adenoma formation in familial adenomatous polyposis. Gastroenterology. 2000;118:A657.","journal-title":"Gastroenterology"},{"issue":"8","key":"354_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/jama.286.8.954","volume":"286","author":"D Mukherjee","year":"2001","unstructured":"Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001 Aug;286(8):954\u201359. https:\/\/doi.org\/10.1001\/jama.286.8.954.","journal-title":"JAMA"},{"issue":"6","key":"354_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1006\/pmed.1997.0242","volume":"26","author":"K Imai","year":"1997","unstructured":"Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med. 1997 Nov-Dec;26(6):769\u201375. https:\/\/doi.org\/10.1006\/pmed.1997.0242.","journal-title":"Prev Med"},{"issue":"10","key":"354_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/j.1349-7006.1988.tb01528.x","volume":"79","author":"S Kono","year":"1988","unstructured":"Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res. 1988 Oct;79(10):1067\u201374. https:\/\/doi.org\/10.1111\/j.1349-7006.1988.tb01528.x.","journal-title":"Jpn J Cancer Res"},{"issue":"11","key":"354_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1349-7006.1990.tb02520.x","volume":"81","author":"I Kato","year":"1990","unstructured":"Kato I, Tominaga S, Matsuura A, Yoshii Y, Shirai M, Kobayashi S. A comparative case-control study of colorectal cancer and adenoma. Jpn J Cancer Res. 1990 Nov;81(11):1101\u201308. https:\/\/doi.org\/10.1111\/j.1349-7006.1990.tb02520.x.","journal-title":"Jpn J Cancer Res"},{"issue":"6","key":"354_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1349-7006.1989.tb01666.x","volume":"80","author":"Y Fujita","year":"1989","unstructured":"Fujita Y, Yamane T, Tanaka M, Kuwata K, Okuzumi J, Takahashi T, Fujiki H, Okuda T. Inhibitory effect of (\u2212)-epigallocatechin gallate on carcinogenesis with N-ethyl-N\u2019-nitro-N-nitrosoguanidine in mouse duodenum. Jpn J Cancer Res. 1989 Jun;80(6):503\u201305. https:\/\/doi.org\/10.1111\/j.1349-7006.1989.tb01666.x.","journal-title":"Jpn J Cancer Res"},{"issue":"12","key":"354_CR9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1349-7006.1991.tb01801.x","volume":"82","author":"T Yamane","year":"1991","unstructured":"Yamane T, Hagiwara N, Tateishi M, Akachi S, Kim M, Okuzumi J, Kitao Y, Inagake M, Kuwata K, Takahashi T. Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn J Cancer Res. 1991 Dec;82(12):1336\u201339. https:\/\/doi.org\/10.1111\/j.1349-7006.1991.tb01801.x.","journal-title":"Jpn J Cancer Res"},{"issue":"10","key":"354_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1349-7006.1993.tb02792.x","volume":"84","author":"T Narisawa","year":"1993","unstructured":"Narisawa T, Fukaura Y. A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res. 1993 Oct;84(10):1007\u201309. https:\/\/doi.org\/10.1111\/j.1349-7006.1993.tb02792.x.","journal-title":"Jpn J Cancer Res"},{"issue":"1","key":"354_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1349-7006.2006.00348.x","volume":"98","author":"Y Yamada","year":"2007","unstructured":"Yamada Y, Mori H. Multistep carcinogenesis of the colon in Apc(Min\/+) mouse. Cancer Sci. 2007 Jan;98(1):6\u201310. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00348.x.","journal-title":"Cancer Sci"},{"key":"354_CR12","first-page":"40","volume":"5","author":"S Tokudome","year":"2004","unstructured":"Tokudome S, Goto C, Imaeda N, Tokudome Y, Ikeda M, Maki S. Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pac J Cancer Prev. 2004;5:40\u201343.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"354_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2468-1253(21)00018-2","volume":"6","author":"H Ishikawa","year":"2021","unstructured":"Ishikawa H, Mutoh M, Sato Y, et al. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial. Lancet Gastroenterol Hepatol. 2021;6(6):474\u201381.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"354_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/s0278-6915(00)00109-5","volume":"38","author":"M Lodovici","year":"2000","unstructured":"Lodovici M, Casalini C, De Filippo C, Copeland E, Xu X, Clifford M, Dolara P. Inhibition of 1,2-dimethylhydrazine-induced oxidative DNA damage in rat colon mucosa by black tea complex polyphenols. Food Chem Toxicol. 2000 Dec;38(12):1085\u201388. https:\/\/doi.org\/10.1016\/s0278-6915(00)00109-5.","journal-title":"Food Chem Toxicol"}],"container-title":["Genes and Environment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41021-026-00354-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41021-026-00354-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41021-026-00354-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:09:04Z","timestamp":1781636944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41021-026-00354-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1186\/s41021-026-00354-2","relation":{},"ISSN":["1880-7062"],"issn-type":[{"value":"1880-7062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"After approval by the Institutional Review Board of the Osaka Prefectural Adult Disease Center, the study was conducted with the approval of the institutional review boards at each participating institution. An independent ethics monitoring committee was established for this study, and patients were continuously monitored throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}